This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Prime Therapeutics Receives Innovators In Business Award For 2012 From Florida Governor Rick Scott

ST. PAUL, Minn. , Dec. 21, 2012 /PRNewswire/ -- Prime Therapeutics (Prime) has been awarded the 2012 Innovators in Business – Governor's Newcomer Award by Florida Governor Rick Scott for the outstanding contributions of Prime Therapeutics Specialty Pharmacy to the state's economic growth. Prime was honored during an evening reception at the Florida Governor's mansion in Tallahassee, FL on Dec. 10, 2012.

"We are pleased to see our commitment to the economic development of this region recognized through this prominent award," said Eric Elliott, president and CEO of Prime. "We are proud of the 122 professionals currently employed at Prime Specialty Pharmacy who are dedicated to providing our members easier access to more affordable medicines so they can feel better and live well."   

The Governor's Innovators in Business Awards recognize outstanding contributions toward improving and diversifying Florida's economy plus distinctive community investment efforts, particularly relating to industries targeted for economic development and high wage job growth.  

"My number one mission is to grow jobs for Florida families, and the successes these companies have experienced represent the job opportunities being created in Florida," said Governor Rick Scott.

Prime Specialty Pharmacy is expanding the company's ability to manage specialty medicine functions and is projected to create 213 new jobs for the region over the next three years.  Medications managed and delivered by the specialty pharmacy are often used to treat complex and chronic conditions such as multiple sclerosis, hepatitis C and cancer. The facility has been operating since early August with specialty pharmacy order processing, care management, fulfillment, billing and customer service.

About Prime Therapeutics Prime Therapeutics, a leader in pharmacy benefit management, is dedicated to making it easier for our nearly 20 million members to obtain more affordable medicines. We leverage our unique connections to deliver programs that lead to the best health outcomes for our members.

Headquartered in St. Paul, Minn., Prime Therapeutics serves nearly 20 million people and is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans.

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.

SOURCE Prime Therapeutics

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs